The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

24 Jun 2016 12:15

RNS Number : 2346C
Proxama PLC
24 June 2016
 

Neither this announcement nor any part of it constitutes an offer to sell or issue or the solicitation of an offer to buy, subscribe or acquire any securities in any jurisdiction in which any such offer or solicitation would be unlawful and the information contained herein is not for publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, South Africa or any jurisdiction in which such publication or distribution would be unlawful.

 

Proxama Plc

 ("Proxama" or the "Company")

Result of Placing

 

Proxama PLC (AIM: PROX), the leading mobile proximity marketing expert, is pleased to announce the successful completion of the placing announced earlier today (the "Placing").

 

A total of 666,666,666 New Ordinary Shares of the Company (the "Placing Shares") have been placed by Peel Hunt LLP ("Peel Hunt") at a price of 0.3 per share (the "Placing Price"), representing a 58.6 per cent discount to the closing price on 23 June 2016 (being the day prior to this announcement) with new and existing investors, raising gross proceeds of approximately £2.0 million (approximately £1.9 million net of expenses).

 

The Placing Shares will represent approximately 64.1 per cent. of the Existing Ordinary Shares and approximately 39.1 per cent. of the enlarged share capital.

 

John Kennedy, CEO of Proxama, said:

 

"I would like to thank our existing and new shareholders for the faith they have put in Proxama and look forward to updating shareholders on our progress in the months ahead."

 

Directors' participation

 

Directors of the Company have, in aggregate, invested £260,000 of the funds raised in the Placing.

The participation of the Directors of the Company in the Placing is set out in the table below:

Director

Beneficial holding of Ordinary Shares before the Placing

Number of Placing Shares to be purchased

Beneficial holding of Ordinary Shares after the Placing

% of expected enlarged share capital

Gavin Breeze, Non- Executive Director

150,006,651

66,666,666

216,673,317

12.7%

David Bailey, Non-Executive Chairman

12,824,126

20,000,000

32,824,126

1.9%

 

Related Party Transaction

The participation by David Bailey and Gavin Breeze in the Placing constitutes a related party transaction for the purposes of the AIM Rules. John Kennedy, Mike Woods and Shaun Gregory, who are independent directors for the purposes of the Proposals, having consulted with the Company's nominated advisor, Peel Hunt, consider that the terms of the related party transactions are fair and reasonable insofar as the Company's shareholders are concerned.

General Meeting

The Company intends to send a circular to its shareholders shortly to convene a General Meeting of the Company to be held at Taylor Vinters LLP, Tower 42, 33rd Floor, 25 Old Broad Street, London EC2N 1HQ at 2:15 pm on 25 July 2016.

At the General Meeting, resolutions of the Company will be proposed to give the directors of the Company (the "Directors") authority to issue and allot the Placing Shares on a non pre-emptive basis pursuant to the Placing. In order to issue and allot the Placing Shares, resolutions will also be proposed to subdivide the share capital of the Company and amend the Company's articles of association to reflect such subdivision.

In order for the Placing to take place, the Resolution must be passed. If the Resolutions are not passed, it will not be possible for the Placing to take place.

Expected timetable

Posting of circular and proxy form to shareholders

on 27 June 2016

Latest time for receipt of Forms of Proxy

2.15 p.m. on 23 July 2016

General Meeting

2.15 p.m. or as soon as possible after the AGM, on 25 July 2016

Record date for the Subdivision

Close of business on 25 July 2016

Subdivision effective

8.00 a.m. on 26 July 2016

Admission and commencement of dealings in the New Ordinary expected to commence on AIM

8.00 a.m. on 26 July 2016

CREST accounts expected to be credited

26 July 2016

Definitive share certificates to be dispatched by

9 August 2016

 

Enquiries:

For further Information:

 

Proxama PLC

John Kennedy, Chief Executive

020 3668 2888

 

Peel Hunt LLP

(Nominated Adviser and Broker)

Richard Kauffer

Euan Brown

020 7418 8900

Novella

Tim Robertson

Ben Heath

020 3151 7008

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGUUUQUPQGGC
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.